Medicare Part D beneficiaries face rising out-of-pocket costs for brand name drugs The Expe…

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, according to…

Continue ReadingMedicare Part D beneficiaries face rising out-of-pocket costs for brand name drugs The Expe…